 James Lambert
Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcitriol | 5 | 2016 | 53 | 1.610 |
Why?
| | Growth Differentiation Factor 15 | 6 | 2019 | 33 | 1.450 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2018 | 157 | 1.030 |
Why?
| | Receptors, Steroid | 3 | 2015 | 47 | 1.010 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2016 | 147 | 0.990 |
Why?
| | Neoplasm Proteins | 2 | 2016 | 385 | 0.850 |
Why?
| | Antineoplastic Agents | 7 | 2021 | 1879 | 0.830 |
Why?
| | Vitamin D | 3 | 2016 | 341 | 0.780 |
Why?
| | Prostatic Neoplasms | 7 | 2019 | 921 | 0.780 |
Why?
| | Focal Adhesions | 2 | 2016 | 42 | 0.630 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2019 | 1141 | 0.530 |
Why?
| | Cell Line, Tumor | 13 | 2019 | 2710 | 0.530 |
Why?
| | Actin Cytoskeleton | 1 | 2016 | 93 | 0.510 |
Why?
| | Receptors, Glucocorticoid | 4 | 2015 | 130 | 0.490 |
Why?
| | Response Elements | 3 | 2015 | 82 | 0.480 |
Why?
| | Cell Adhesion | 1 | 2016 | 432 | 0.480 |
Why?
| | Tumor Suppressor Protein p53 | 4 | 2008 | 445 | 0.480 |
Why?
| | Prostatitis | 1 | 2014 | 18 | 0.470 |
Why?
| | Transcription, Genetic | 5 | 2013 | 1313 | 0.450 |
Why?
| | Prostate | 1 | 2014 | 156 | 0.430 |
Why?
| | Connective Tissue Growth Factor | 1 | 2013 | 21 | 0.430 |
Why?
| | Receptors, Calcitriol | 2 | 2010 | 53 | 0.420 |
Why?
| | Promoter Regions, Genetic | 7 | 2015 | 1131 | 0.420 |
Why?
| | Cell Movement | 2 | 2016 | 869 | 0.410 |
Why?
| | Gene Expression Regulation | 5 | 2015 | 2320 | 0.380 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 281 | 0.380 |
Why?
| | Alkylating Agents | 1 | 2010 | 27 | 0.360 |
Why?
| | NF-kappa B | 1 | 2014 | 641 | 0.360 |
Why?
| | Prostatic Hyperplasia | 1 | 2008 | 38 | 0.300 |
Why?
| | Cell Hypoxia | 1 | 2008 | 221 | 0.290 |
Why?
| | Calcifediol | 1 | 2007 | 29 | 0.290 |
Why?
| | Kidney Neoplasms | 1 | 2010 | 327 | 0.270 |
Why?
| | Protein Binding | 4 | 2015 | 1890 | 0.270 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 351 | 0.270 |
Why?
| | DNA Damage | 1 | 2008 | 351 | 0.270 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2006 | 132 | 0.260 |
Why?
| | Apoptosis | 5 | 2019 | 2363 | 0.250 |
Why?
| | Mammary Tumor Virus, Mouse | 2 | 2015 | 42 | 0.240 |
Why?
| | Melanoma | 2 | 2021 | 620 | 0.240 |
Why?
| | Anti-Bacterial Agents | 2 | 2011 | 1481 | 0.230 |
Why?
| | DNA | 3 | 2015 | 1352 | 0.210 |
Why?
| | Receptors, Progesterone | 2 | 2013 | 319 | 0.210 |
Why?
| | Neoplasms | 2 | 2013 | 2097 | 0.180 |
Why?
| | Trans-Activators | 1 | 2003 | 367 | 0.180 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2020 | 22 | 0.180 |
Why?
| | Aniline Compounds | 1 | 2020 | 70 | 0.170 |
Why?
| | Nuclear Proteins | 2 | 2008 | 591 | 0.170 |
Why?
| | Humans | 26 | 2021 | 114689 | 0.170 |
Why?
| | Organoselenium Compounds | 1 | 2019 | 11 | 0.170 |
Why?
| | Histones | 2 | 2010 | 535 | 0.170 |
Why?
| | Transcriptional Activation | 5 | 2012 | 337 | 0.170 |
Why?
| | Protein Multimerization | 3 | 2015 | 157 | 0.160 |
Why?
| | Cell Proliferation | 2 | 2019 | 2187 | 0.160 |
Why?
| | Transfection | 3 | 2016 | 866 | 0.150 |
Why?
| | Thermodynamics | 3 | 2015 | 382 | 0.150 |
Why?
| | Phosphorylation | 2 | 2013 | 1569 | 0.150 |
Why?
| | Cell Division | 2 | 2012 | 758 | 0.150 |
Why?
| | Tryptophan | 1 | 2018 | 136 | 0.140 |
Why?
| | Prodigiosin | 2 | 2007 | 2 | 0.140 |
Why?
| | Neoplasm Invasiveness | 2 | 2016 | 442 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2010 | 398 | 0.140 |
Why?
| | Sulfonamides | 1 | 2020 | 445 | 0.140 |
Why?
| | Matrix Metalloproteinase 10 | 1 | 2016 | 3 | 0.140 |
Why?
| | rac GTP-Binding Proteins | 1 | 2016 | 34 | 0.130 |
Why?
| | Cell Cycle | 2 | 2010 | 542 | 0.130 |
Why?
| | Laminin | 1 | 2016 | 69 | 0.130 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2016 | 73 | 0.130 |
Why?
| | src-Family Kinases | 1 | 2016 | 88 | 0.130 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 157 | 0.130 |
Why?
| | Oncogenes | 1 | 2016 | 103 | 0.130 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2016 | 180 | 0.120 |
Why?
| | Ultracentrifugation | 1 | 2015 | 46 | 0.120 |
Why?
| | Signal Transduction | 5 | 2016 | 4513 | 0.120 |
Why?
| | Mice, Nude | 2 | 2020 | 630 | 0.120 |
Why?
| | Skin Neoplasms | 1 | 2021 | 756 | 0.120 |
Why?
| | RNA Interference | 1 | 2016 | 433 | 0.120 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 523 | 0.120 |
Why?
| | Atrophy | 1 | 2014 | 152 | 0.110 |
Why?
| | Homeodomain Proteins | 2 | 2010 | 463 | 0.110 |
Why?
| | Receptors, Estrogen | 2 | 2015 | 372 | 0.110 |
Why?
| | Luteolin | 1 | 2013 | 2 | 0.110 |
Why?
| | Quercetin | 1 | 2013 | 11 | 0.110 |
Why?
| | Mutation, Missense | 1 | 2015 | 293 | 0.110 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2013 | 27 | 0.110 |
Why?
| | Integrin alphaVbeta3 | 1 | 2013 | 20 | 0.110 |
Why?
| | Two-Hybrid System Techniques | 1 | 2013 | 52 | 0.110 |
Why?
| | Endocrine Disruptors | 1 | 2013 | 34 | 0.110 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2013 | 89 | 0.100 |
Why?
| | MicroRNAs | 1 | 2018 | 600 | 0.100 |
Why?
| | Antigens, CD | 1 | 2014 | 442 | 0.100 |
Why?
| | Sodium Chloride | 1 | 2012 | 136 | 0.100 |
Why?
| | Cytokines | 2 | 2011 | 1841 | 0.090 |
Why?
| | Evolution, Molecular | 1 | 2015 | 430 | 0.090 |
Why?
| | Steroid Hydroxylases | 1 | 2011 | 19 | 0.090 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2011 | 14 | 0.090 |
Why?
| | Salmonella typhi | 1 | 2011 | 11 | 0.090 |
Why?
| | Alkylation | 1 | 2010 | 18 | 0.090 |
Why?
| | Animals | 9 | 2021 | 31706 | 0.090 |
Why?
| | Cyclin A | 1 | 2010 | 15 | 0.090 |
Why?
| | Mice | 6 | 2021 | 14869 | 0.090 |
Why?
| | Nuclear Receptor Coactivator 3 | 1 | 2010 | 6 | 0.090 |
Why?
| | Male | 10 | 2019 | 55599 | 0.090 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 399 | 0.090 |
Why?
| | Blotting, Western | 2 | 2010 | 1147 | 0.090 |
Why?
| | Immunoenzyme Techniques | 1 | 2010 | 192 | 0.090 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 300 | 0.080 |
Why?
| | Dietary Supplements | 1 | 2013 | 460 | 0.080 |
Why?
| | Caspases | 1 | 2010 | 245 | 0.080 |
Why?
| | Receptors, Androgen | 1 | 2010 | 131 | 0.080 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 849 | 0.080 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2008 | 4 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2010 | 698 | 0.080 |
Why?
| | CREB-Binding Protein | 2 | 2010 | 27 | 0.080 |
Why?
| | Cell Count | 1 | 2008 | 303 | 0.070 |
Why?
| | RNA Stability | 1 | 2008 | 90 | 0.070 |
Why?
| | Huntington Disease | 1 | 2008 | 39 | 0.070 |
Why?
| | Acetylation | 2 | 2010 | 211 | 0.070 |
Why?
| | Doxorubicin | 1 | 2008 | 285 | 0.070 |
Why?
| | Escherichia coli | 1 | 2011 | 720 | 0.070 |
Why?
| | Fibroblast Growth Factors | 1 | 2008 | 162 | 0.070 |
Why?
| | Corpus Striatum | 1 | 2008 | 126 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 107 | 0.070 |
Why?
| | Rats, Nude | 1 | 2006 | 26 | 0.070 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2007 | 77 | 0.070 |
Why?
| | RNA, Neoplasm | 1 | 2006 | 80 | 0.070 |
Why?
| | Biological Transport | 1 | 2007 | 373 | 0.070 |
Why?
| | Transplantation, Heterologous | 1 | 2006 | 181 | 0.070 |
Why?
| | Calcium | 1 | 2012 | 1108 | 0.070 |
Why?
| | Time Factors | 1 | 2016 | 6116 | 0.060 |
Why?
| | Tumor Suppressor Proteins | 1 | 2008 | 282 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 510 | 0.060 |
Why?
| | Repressor Proteins | 1 | 2008 | 366 | 0.060 |
Why?
| | Female | 6 | 2018 | 59511 | 0.060 |
Why?
| | Transforming Growth Factor beta | 1 | 2007 | 448 | 0.060 |
Why?
| | DNA Footprinting | 2 | 2015 | 28 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 740 | 0.060 |
Why?
| | Binding Sites | 3 | 2012 | 1168 | 0.060 |
Why?
| | Breast Neoplasms | 3 | 2013 | 1862 | 0.050 |
Why?
| | Disease Models, Animal | 1 | 2012 | 3535 | 0.050 |
Why?
| | Uveal Neoplasms | 1 | 2021 | 8 | 0.050 |
Why?
| | Precancerous Conditions | 1 | 2003 | 158 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2008 | 1314 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 213 | 0.040 |
Why?
| | Chromatin | 1 | 2003 | 428 | 0.040 |
Why?
| | Tryptophan Oxygenase | 1 | 2018 | 22 | 0.040 |
Why?
| | Rats | 1 | 2006 | 4958 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1518 | 0.040 |
Why?
| | Kynurenine | 1 | 2018 | 81 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 167 | 0.030 |
Why?
| | Androgens | 2 | 2010 | 167 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2015 | 63 | 0.030 |
Why?
| | Proteomics | 1 | 2019 | 836 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1016 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 616 | 0.030 |
Why?
| | Luciferases | 1 | 2012 | 142 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1230 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1551 | 0.020 |
Why?
| | Hydrodynamics | 1 | 2011 | 37 | 0.020 |
Why?
| | RNA, Messenger | 2 | 2008 | 2553 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2010 | 151 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 2010 | 151 | 0.020 |
Why?
| | Huntingtin Protein | 1 | 2008 | 10 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1369 | 0.020 |
Why?
| | Base Sequence | 1 | 2012 | 2114 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2008 | 133 | 0.020 |
Why?
| | Dioxoles | 1 | 2007 | 9 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2785 | 0.020 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2007 | 52 | 0.020 |
Why?
| | Genes, Neoplasm | 1 | 2007 | 20 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2007 | 60 | 0.020 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2007 | 26 | 0.020 |
Why?
| | Benzamides | 1 | 2007 | 169 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 171 | 0.020 |
Why?
| | Down-Regulation | 1 | 2008 | 594 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 923 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2010 | 951 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2012 | 3886 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 529 | 0.010 |
Why?
| | Cell Survival | 1 | 2007 | 1021 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 1949 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1629 | 0.010 |
Why?
| | Chromosome Aberrations | 1 | 2003 | 135 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 1701 | 0.010 |
Why?
| | Phenotype | 1 | 2008 | 2796 | 0.010 |
Why?
| | Transcription Factors | 1 | 2008 | 1528 | 0.010 |
Why?
| | Middle Aged | 1 | 2008 | 26737 | 0.000 |
Why?
|
|
Lambert's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|